{"3fe09fafae1c4200bf36faea155c3c62": "", "354a06365eb5430db7d04eb6bea5af55": "rna polymerase ii", "1126a2a0c1ae4863844e2b5cc811f042": "bacillus subtilis", "1e1ef110e6154949bc822e542fff38e2": "[CLS]", "344f79431db040ea8cbbb6cb3a1b171a": "fibrillar <unk>-synuclein", "ba84f91cf9b6461d9ee02be446bcdffc": "chediak-higashi syndrome", "345ca0bfb3974062abd3ec10a6cbc84a": "[CLS]", "e4f9aab09e074c42b56d239bd1ea6bf9": "monophyletic origin of alu and b1 repeats, i.e., from a common 7sl rna-derived retroposing monomeric element", "db3d5700fb404c9d9b22de58652e441b": "[CLS]", "f69aed865e4f4461b59e86ff393595b6": "restless legs syndrome", "23231ba1735c46b7b4dbacd35b95a111": "rfx6", "d99ab786d2ec4d17b1540cf721370ef0": "[CLS]", "c56e3d34c08a4d009fb83d8ed37c636a": "autosomal dominant", "e662d0daac3047e6bbb879f08d0a56eb": "[CLS]", "ad2342b8121d4fafa653d33df74f5afc": "restless legs syndrome", "071541cdeb9e4d6c9a4b372f6a11c778": "[CLS]", "0029838703954d16a57a5cc158fd86d5": "bone metabolism", "83d7f282309948759aa19ff5ddcdd45c": "autosomal dominant romano-ward form", "94fef0193ac04cd1bd0618898b7f9efd": "[CLS]", "c35f27d4167846e1adc3aadd2981e4dc": "ptsd", "767ca74416ef41738a08d2aef5208410": "flumazenil", "b5b0517d354847768bfb0266b7052a80": "xk", "30982bbba290475cadfbcc0116b0d9c4": "xk", "fdc8771a13204b6eb28d48a0e3f1d6c5": "nox1", "d6e9cee2def349948db2eae4577d1aaa": "dabigatran", "7b72b7fbe25641d2afc299fbcc7284d8": "[CLS]", "ae5bb34ab378486298ab61b3973ece7b": "[CLS]", "89d94b385eb34bc8ba92ccfb2605442f": "alpha-synuclein", "09a953250a1f4db4816c782183c4fa89": "[CLS]", "9c678887061c48e688347d3c09889e6c": "[CLS]", "b57cadd16f7a4c1795c6018b46b69e57": "[CLS]", "f33d6fecbf754206bd68d7fc7adad530": "lysosomal membrane", "2218c4979008424a9f948a7b71448a42": "restless legs syndrome", "e20b24502922481885eab94b612f374d": "[CLS]", "fda25d478d054f8bb5e7cf002113e5e8": "[CLS]", "34757c8e5ca444a192856060543f7791": "autosomal dominant", "6e6cc6752f9047989d4703ae6d6c8051": "flumazenil", "b37db289ef2948e9b5e75fbc0cbd66bf": "[CLS]", "353a222964794361bdaaf8ea481c12ee": "ataxin-3", "4a93e831ea4b4c5fb6f059f0b2cca5be": "caspase-cleaved tdp-43", "fd787f32d19848dbb65fe34c00222562": "[CLS]", "354f714bfea84f6b8e02e7acba3f7d67": "nf1 tumor-suppressor gene", "67b5647fc6814b5d880a3bc12a5c419c": "autosomal recessive", "4499cb8591df4db39618e8fc1992e197": "[CLS]", "47da715dad124f3690dc1764042458cc": "[CLS]", "db97a187c75442e883f177344a687937": "[CLS]", "5389373ddbe048119c1dbeb0494dd528": "[CLS]", "4504ae5e0d41435984b259c276b8cf7f": "<unk>-synuclein", "4b0eb00ff2664722917b55ccb33b9689": "[CLS]", "d4ee2e1fb7364cd6bb5931d72186c5bb": "[CLS]", "9305f4338a854725ab83e9b81c3c35b4": "pneumoperitoneum", "98e46197609848b39e1fb5db6b9f7fa8": "<unk>-synuclein", "6c15c6c5007f4bac9ec1454df2719dfa": "dabigatran", "179e834f3f064c7188755ef9596db9d9": "ataxin-3 protein", "92d38fcd3d864c5aa90a01fe0e5787f2": "dabigatran", "842999d9925347eca644cb9699a36b65": "alpha-synuclein", "a9c0c53d05f1474083e2f1ad8ea28756": "[CLS]", "7161d325e39f4f4884391fb5e3adb5db": "serine 129 (ser129)", "39ab6d3436864e6ea8cc1a577a441db5": "[CLS]", "26694e93ebbc4962895a9d5377a2e4e8": "[CLS]", "66854406960a4a4ba4cff23625202de8": "max methicillin-resistant staphylococcus aureus", "85a18e64fb2d47b0afeee4832c599891": "bcr/abl", "c3272be6bdea40c9ac22dfe5337dc311": "zinc finger e-box-binding homeobox 2 (zeb2) gene", "7b387c3302ca4a718ed588d6618acea4": "[CLS]", "792b104e025543b5b32f47d3bb1b5c44": "antiparallel", "62dfb0f0049641648b339a94e27b7262": "p. vivax", "0c06ab7dd90c4dad83de126afa2b4101": "[CLS]", "3624fe9b9dca47c98be7dc8c2d2db870": "027", "e876f360fb1c426aaf2c11c8f1ff0327": "meningioma", "072774d22d1943ada30195f317483bf3": "methicillin-resistant staphylococcus aureus", "0c2e363266584674a6c79cd1c7d3e1eb": "[CLS] what tyrosine kinase, involved in a philadelphia- chromosome positive chronic myelogenous leukemia, is the target of imatinib (gleevec)?[SEP] chronic myeloid leukemia (cml) is characterized by the presence of the philadelphia chromosome, which is associated with a balanced translocation involving chromosomes 9 and 22 to produce a fusion gene (bcr-abl) that gives rise to a constitutively activated abl", "d451ee65e0e14baaa98a29b68092c5fc": "[CLS]", "d8dc6dcb02604df98e1a216e74a229fa": "", "e7dd43f614bd4a44808e13eb2dbde1f6": "[CLS]", "7612f12628274b6dbdc14d2f9a22855f": "", "c83c84f9c33345268a80de699a70104f": "", "8cb2d5ed371845bdbc1aef1bc23e2418": "alpha-synuclein", "a02c851b01e7465280df78b10bd835f5": "ventral intermediate thalamic nucleus", "3216ab3e241a45eea283765e3bee89ef": "[CLS]", "b7441dc6481f4a8c8ea767fe70d618bb": "[CLS]", "3d080e8520c34ceca932d863f5e88a76": "[CLS]", "8879689c14314feb9629e3d724500547": "[CLS]", "13712b1db9094ec2bd023d0036495b5d": "bazex syndrome", "817590b6c9a647a5aef10b85199aef9b": "spleen tyrosine kinase", "f252703de7194f1983547f4bf860ba40": "xk gene", "1943cdaa336f472f827be07ba6e57bb5": "<unk>-synuclein", "464136c1262c4537a73e251dcc6d6f54": "[CLS]", "513ee6b7112740b7afa36d176c0f833f": "[CLS]", "08f0df88d96347d39f79a425ef636d4b": "027", "5972815d8210470eb84c3da30f0aa090": "an antioxidant", "76475db3f85f4bccba0b5febb2054087": "[CLS]", "88255af0d4234ad09cdee7305967cf18": "[CLS]", "6f535f0663104aabbe0325e73769505f": "antiparallel", "4688b81a249a4edd87b46d5ce300cfcf": "lamp2a", "8708371a1d3b41c89c378772ccbe6fb2": "secis", "f39ba0ef13d74fbbbee6b6a7495a7da1": "posttraumatic stress disorder", "d6994d74aee440879b8c68ca849fa9db": "chediak-higashi syndrome", "34689931e2824bf58d7aa234d7a4eed3": "48", "9bf503906c3b425bb54cf156d27e9101": "rac1", "3a09c991f94d49ac9f85560e9ef63b8f": "[CLS]", "cecd920cbb724d98aaf99c70c2dcc371": "[CLS]", "657d5d7eecf249cb96e36f5b3a818fcf": "[CLS]", "a4da3f3b9ad440b69aaf79b7d6f6f893": "alpha-synuclein", "e29d0b192b44413e95a08a2afa14fcbc": "zfhz1b", "04cb5e56a4624e849a6e56966d0d643e": "[CLS]", "2955684affa14660b9c3b54689b9b2d2": "[CLS]", "08994280294d46b78596738f2a8bd39a": "[CLS]", "a41b67e4e4004aa6a155ea9bb5d45fc4": "[CLS]", "84268ced61744024a40b6f8d2316d275": "alpha-synuclein and ubiquitin", "bba18f5535f945b98b8a82421bcbe956": "posttraumatic stress disorder (ptsd)", "da32f12980d845719c03c2c03494afe1": "[CLS]", "ba508f5b8dfb4fbc83ecf9831706b686": "zfhx1b", "c24c1289233c489691969ee391245427": "[CLS]", "d74834afd23a4192b6b88ed137c2ea87": "[CLS]", "e3fcd872a2a34c279d4633b77cd0d266": "nsd1", "ccaf40e8947045dbb86dafd325b2f626": "lyst", "0bede4582a9e40d4bb498c8ee7d6c64e": "[CLS]", "141c4f0d6d4d4916a34c9dae06adcc8a": "slc9a6", "7ff12940e9c34f73936d58aa6f5f4f8b": "xk", "412a49803a00424099cd84a75d92bd63": "[CLS]", "df45d243d5b846c9b8dd26f62bbe479e": "formin", "4f93de9591b34369ba45f43f3f6efb52": "[CLS]", "250caa665c8448fb98e285306f80e63e": "base-excision repair", "fb6050311b794585986ab4a8b17b564e": "[CLS]", "dc9bceb110f546b884dbdd371fc5a5b9": "[CLS]", "61ec5684d44c4296809c466509051021": "inhibits tcr-mediated signal transduction, cellular proliferation", "cdd96acd2fc94e268b146391bc401383": "[CLS]", "16a25da84839436a89074d9ddedd979f": "restless legs syndrome", "3edca0aa7f0d4e7fba97191c13e28d28": "cornelia de lange syndrome", "ae333a083631463086544ba27a982cf1": "methicillin-resistant staphylococcus aureus", "7bd8a7a1bafe47c3abd747f77a580738": "median nerve", "2d73138d00bc4dfc99e39ba6f78babb8": "[CLS]", "7bc7d50257d34f87ab4fb5cf15488ef8": "slc9a6", "513f317b2bbb49a488431854ec8b1291": "(spt-ada-gcn5-acetyltransferase)", "5658da3cc5b84d219d6f6991552febf0": "[CLS]", "9095328339f447188880bc5412e035d4": "zfhx1b gene", "b2f73e6827624d46a50622245bc0bc8c": "notch3", "24a13e3726da44deb5ad15627d9c04f8": "chronic pain", "33f0175a3dd1410a979d8698198ca39b": "notch3 gene", "d38d490c5d9f45a0818bec552463879b": "receptor activator of nuclear factor <unk>b ligand", "3dff550077ca471a8137430b2d11722c": "autosomal dominant inheritance", "ccb9b1d3df6f45b2bb19557def943330": "chronic low back pain", "f129d78a420746cd9b0364aa8ac1fa28": "[CLS]", "1bcd341d9896445e8554027ad01ed066": "alpha-proteobacterium", "91ba5f0e9cdb420b8e49daf63935d388": "<unk>-galactosidase", "2270a17d1c8b4ecba24ad304bcb2f5ad": "<unk>-synuclein", "204004adaf394da29332aa0a6d83a243": "plakoglobin", "976535f8681e45c9881400b1e940a908": "[CLS]", "4dddb3b7e1e446fe922c7789a90fc99f": "skin", "34237e2593fe47159c2577f4c10f4577": "[CLS]", "86bd299403624adfa79bf2ac1de79528": "[CLS]", "a599caa6467c4126af22518a18e24c41": "[CLS]", "ea59c7ee76424a47bdecc74c9987666f": "aging studies", "4db9416efbb340a49f9352809ab90a84": "[CLS]", "55f7e26b1a6a41c08f110ecb1c372358": "late", "b0c5cb7e458c48f9a369b023a6f154ef": "(prd)", "d053f9773d0649b8b2acea49e06af19f": "fibroblast growth factor receptor 3 (fgfr3) gene", "2e818059dd7c4f0d898f3266677d9a3c": "[CLS]", "e37eef543acc42c0902146dfb8efe1c7": "[CLS]", "8e8bc2fb6f4f494c94d828de7c279203": "[CLS]", "f40c5ca38b964c3fbfd353444320a3b9": "41", "1c5db62efbc145768b9fd53df6a404d5": "receptor-mediated endocytosis to be defective in cln3-deficient jncl fibroblasts", "66ed19703ab9429588260046aacc2ac1": "slc9a6", "2b04e73544f7459d9232316ec0e13a4a": "programmed death receptor-1", "9017897d71c2434d90f474f17544eebd": "[CLS]", "dd55ff8b09a7433aa467295dae5b0c62": "men", "54d034854e514d05b8be8c343c9d0484": "methicillin-resistant staphylococcus aureus", "2f91c196e1e14427999116eb471acf92": "[CLS]", "ee5c985a3d3b4cd89647bbe76b8def7b": "[CLS]", "c52217c869064579a2201e621fdbf60c": "lysine 4", "6058f2f8356844f09683a30ad50f344f": "[CLS]", "6c9b255f11a04caa992ae6ef8de912b0": "", "d30650e611f64f46abbf5b525ce53a92": "(lhcii)", "efb13b867d664aa1b52ab77cba850165": "soft connective tissues", "5c2cbb8eaf4742919bc8a56682ea0e5a": "[CLS]", "c9db9e67e67b4c408b9e053169e05a70": "nf1", "69c3caa799bb4990932019ccbabd967e": "alpha-synuclein", "2a8c06afe76f42f9ab06708b3adc27fc": "[CLS]", "15acdfafb8db4713a4ed63acfd61cd30": "[CLS]", "966b0a95d1b84227ac890a3daaef2086": "molecular functions", "a118373d91094ae6aca3047edf9b0bac": "[CLS]", "6a92b3312fe9468e9d709a8e59c9fadc": "", "72c14e2563a94713baea221bbf150180": "plasmodium spp", "f9b282fbb19a4becb10efa8009e39d88": "surgical site infection", "3005311091144dfdb1464aeae598c703": "[CLS]", "2cf9e36ee549421b84170a93d439b69d": "nsd1 gene", "c5f738e45b874642afbdf22cb1b0c970": "", "4edb95a363144efdb21977cc7f1912a8": "[CLS]", "30f3fe33aa974d54aa12ad555cb22644": "[CLS]", "930ebd41e49942059fff966207ce5c03": "[CLS]", "9bb5d9f90f804b34971f0a239f63343b": "disruption of the yeast gene", "52cd8f90006a41c999627c367f252ff3": "[CLS]", "5fd7a2dfb5344090b95d6ffff8d1456c": "xk gene is x-linked, it would be easy to identify spontaneously arising red cells with a phenotype resembling the mcleod syndrome, which results from inherited xk", "169d1ca25e78425dbd60b6192286d3dd": "[CLS]", "785d411170fb461891f9aaf5794d8c28": "[CLS]", "70d7878277804532b313a72e5e20e286": "naloxone", "77c8c610c2b44cfdadd28ce51c2e8c6b": "[CLS]", "f1bd012a42904b12a152b624439f2533": "imatinib mesylate", "51a1889816af46d0bc6c17f5001e75f4": "[CLS]", "251f6ff810384420b6df79a29f772ff0": "[CLS]", "e9f8a67168b34db5ab3343fb3e9136ae": "methicillin-resistant staphylococcus aureus", "020cf00b943b468f9e50ce04bee47b9f": "motor neuron disease", "c13bddb9e37b47c69428caa895cea7ae": "willis-ekbom disease/restless legs syndrome", "0c569438ed394a3b9e7d3c5ed7abd507": "[CLS]", "7a2e176738494125886c80681e52a70e": "[CLS]", "ec3c96601d8840c58a8302933740c8a2": "[CLS]", "e1caec128d5f4cb4a20159f0430b80d1": "[CLS]", "704744227c8048f0b703848334d6ec87": "catalytic histone methyltransferase set-domain", "4a2d924caf4d464aa5a7837b4e6e320d": "[CLS]", "a26bb24d46114aeaa1d54858c6340119": "<unk>-synuclein", "a9464ddc76874f33bc3080db5c5c07b9": "[CLS]", "62f547c5c52345068b263ed7bbd85032": "cho cells", "9bcff955534e462aad930acfdb1fef0c": "slc9a6", "cf97c5fcf3d94305a47f705ecb7271f5": "alpha-synuclein", "fd51aa90ceb147e78cd27c4328ac7962": "personally normalized plasma protein profiles", "2406a794568840628014804927e40975": "[CLS]", "f86ef5e1ac664cb0a799f69a2e54f94d": "", "d298832c62de4e73ad3b013ea2443d51": "renal glucose reabsorption", "432d404973ba41318c6fe93752543d01": "[CLS]", "838f259cf3d94ed1a4628e26a79fa183": "[CLS] against which protein is the antibody used for immonostaining of lewy bodies raised?[SEP] we immunohistochemically investigated the degeneration processes of the nigro-striatal and nigro-amygdaloid pathways and the relationship between the loss of dopaminergic neurons and lewy bodies (lb) formation in the substantia nigra using 15 autopsied cases of dementia with lewy bodies (dlb). the number of tyrosine hydroxylase (th)-positive neurons in the substantia nigra and th-positive axonal terminals in the putamen decreased with a specific pattern. the substantia nigra possessed alpha-synuclein-positive lb-bearing neurons that were almost evenly distributed, while the putamen exhibited diffuse or granular alpha-synuclein-immunostaining. most of the granular stains were positive for anti-phosphorylated alpha-synuclein", "2c1bd1c29737403c884ad051c6440ed5": "[CLS]", "4bcc2386dcef433497f13c0ffbc668e1": "viroids", "3f7b340bb0f840e98a015f2346104288": "evolutionarily conserved set domain", "bd9c8ec49b8446ba9d107c61a8280a06": "", "c3236d984bae4fe9a702753a63371250": "human immunodeficiency virus", "cdc42c838604450c83009db175c03137": "[CLS]", "0e17fa4dc2be4a299e36c5cf49b2fbee": "[CLS]", "c5bec275c58b4f4e81b005aac5c0e82f": "corynebacterium", "cc706a937ac44341a23ae0cae23e2bdd": "", "9cce10bf0b6546509cf2de1aba61138e": "restless legs syndrome", "f981f754748548ed8b74416b9b29aedd": "[CLS]", "7b813fb8fbe444c2b8ed096bcfc51ca6": "[CLS]", "09ebf96c823548e9a0908cc35606cc13": "syk", "0e24607baaa74369a7171110551ca197": "murine fgfr3", "151aa629d0054dd180576c092fb49055": "skin, ligaments, joints, blood vessels and internal organs", "e71892e90a214ef1be0a9cb61da4dd09": "[CLS]", "84150498c316405889993b5f785ce213": "apoe4", "d161b97805de4abe9ce8e5aff755c987": "dihydrofolate reductase gene", "49df234dddfb4af6b70443ee0df3e00d": "alpha-synuclein (alphas)", "7eb603c02b0c40579e66fe97ee76c19f": "", "fc6f88c8ca2e451284d7c33fa8b5071a": "[CLS]", "0cf3e09ca48743ab8afcd531f7b306e9": "[CLS]", "a5597097671740739398b8d4cab19549": "[CLS]", "682f059c5e1247ec92d678ce3cc5a4cc": "xk", "21b8aedf45d248998d7f1fe63ff3f685": "protein 1 (nsd1)", "d691510d9c1e401ebf6364b876537b48": "chromosome 14", "6960bdbb74c3432a83bd3a3c0a6c30f1": "transcribed strands of expressed genes", "289d6353e4064a62a58db9f9192b3eff": "[CLS]", "0460fc84d839453e88d73ec2691da940": "[CLS]", "18b6217da1e544f0816a04e6db73ff7d": "cysteine", "ec3fbfeea1b541fd86801d3f230fe7ac": "alpha-synuclein", "ee2bb6f12fef47d0a3ddeb7d9f328f4d": "[CLS]", "0852624d3eb84ea89be6dce27c79703c": "flumazenil", "746d6125a1ae4b47b8868da9703ff04b": "staphylococcus aureus", "220f2fda6f7b4ca1a8b1ce1ca1c93bb3": "chronic pain", "dabfffc898254535a9a607a6650d2562": "cysteine", "edddbb8cad694d9a8b64e23dfb8292ba": "[CLS]", "f1f7239d2a0c4cb885c35010f04d0b4a": "", "d4042c8ae89c41c5b5b34e283593ecf2": "iron", "fd6f4f8657ba4d22a07d09f21a98e576": "bcr-abl", "f60eb4dfa5774b8c8a56567d0989deff": "[CLS]", "db82e6a831de4a5e9ce53368a088128a": "[CLS]", "78d3a470a5fc433fb380a0e051deb39c": "methicillin-resistant staphylococcus aureus", "7aee0395db2b4a49bbecaa0dd253b366": "7sl rna gene", "8d3460a44ce34647a536fc55cd18a4e1": "[CLS]", "e77f03a3c71044b98123b465164c6cc7": "[CLS]", "78f0c50b8c6849b2859237d4e919f8cd": "[CLS]", "f00ef1233f084ed28b6eacd36aca14d6": "[CLS] what tyrosine kinase, involved in a philadelphia- chromosome positive chronic myelogenous leukemia, is the target of imatinib (gleevec)?[SEP] imatinib mesylate", "64a4ffe678aa497da235a1cde7d5712e": "[CLS]", "a40ec3c2b8dd4fa4a955eb489be36aa0": "[CLS]", "1a4946e6636c4ab3a37f421bb4397409": "atrial fibrillation and flutter", "85af34b4c81f4eee8ca3336339fad285": "diamond-blackfan anemia", "c09b13353ce8449cae19747d33b78dc2": "[CLS]", "85b37fa6f6cb4803bcf4aa988b62bbac": "[CLS]", "10848a4c98c7472199863319754dae63": "[CLS]"}